Pharma Reviews: GSK bets on specialty drugs, jabs for growth after drab Q1 - Mint

GlaxoSmithKline Pharmaceuticals Ltd's (GSK's) shares have been an underperformer. ... The strong rebound in Indian pharma market growth with improving acute ...
Read more: GSK bets on specialty drugs, jabs for growth after drab Q1 - Mint